xiapex

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2014-2017
02420142017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BACKGROUND Collagenase Clostridium histolyticum (CCH; Xiapex) injections represent the only licensed medical treatment for… (More)
Is this relevant?
Review
2017
Review
2017
INTRODUCTION Peyronie's disease (PD) is a common condition that results in penile deformity, which makes sexual intercourse… (More)
Is this relevant?
Review
2017
Review
2017
Background: Over many decades, the treatment of Dupuytren’s disease, a fibroproliferative disease of the hand, is the centre of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2017
2017
OBJECTIVES To evaluate the efficacy and safety of collagenase clostridium histolyticum (CCH; Xiapex® , Xiaflex® ) in the… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2014
2014
We report a case of acute (24 h) double flexor tendon rupture of the little finger after a single injection of collagenase… (More)
  • table 1
Is this relevant?
2014
2014
Dupuytren's disease (DD) is a common progressive fibroproliferative disorder causing permanent digital contracture. Proliferative… (More)
Is this relevant?
2014
2014
UNLABELLED The purpose of this study was to compare the initial and final outcome range of motion in the MCP-J and PIP-J of… (More)
  • table 1
Is this relevant?
2014
2014
Since October 2011, the enzymatic lysis of Dupuytren's cord was introduced in Switzerland (Xiapex(®), Auxilium Pharmaceuticals… (More)
Is this relevant?
Review
2014
Review
2014
INTRODUCTION The efficiency of collagenase of Clostridium histolyticum (CCH; Xiapex) in the treatment of Dupuytren's contracture… (More)
Is this relevant?